Similarly, autophagy in myeloid-derived suppressor cells’ (MDSCs) inhibits the antitumor immune responses, as evidenced by the report that autophagy-deficient monocytic MDSCs result in efficient activation of tumor-specific CD4+ T cells and improved antitumor immunity (142). The gene discussed is CD4; the disease is neoplasm.